Marco Colasanti
- Hepatocellular Carcinoma Treatment and Prognosis
- Organ Transplantation Techniques and Outcomes
- Liver Disease Diagnosis and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease and Transplantation
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Gallbladder and Bile Duct Disorders
- Cardiac, Anesthesia and Surgical Outcomes
- Pancreatitis Pathology and Treatment
- Liver physiology and pathology
- Pediatric Hepatobiliary Diseases and Treatments
- COVID-19 and healthcare impacts
- Colorectal Cancer Screening and Detection
- Transplantation: Methods and Outcomes
- Gastric Cancer Management and Outcomes
- Abdominal vascular conditions and treatments
- Hepatitis B Virus Studies
- Renal Transplantation Outcomes and Treatments
- Sarcoma Diagnosis and Treatment
- Renal cell carcinoma treatment
- Organ Donation and Transplantation
- Colorectal Cancer Treatments and Studies
- Abdominal Trauma and Injuries
- Reconstructive Surgery and Microvascular Techniques
ASL Roma
2025
Ospedale Sandro Pertini
2025
Carlo Forlanini Hospital
2014-2024
Santa Maria Nuova Hospital
2024
Marche Polytechnic University
2023
Ospedale Vincenzo Cervello
2023
University of Rome Tor Vergata
2023
Centre Hospitalier Universitaire de Grenoble
2022
IRCCS San Camillo Hospital
2013-2022
Hospital Universitario Austral
2022
Previous retrospective studies have shown that sarcopenia substantially alters the postoperative and oncological outcomes after liver resection for malignant tumors. However, evidence is limited to small with heterogeneous results lack of standardized measurements sarcopenia.To investigate role as a risk factor associated 90-day morbidity tumors.This cohort study included 234 consecutive patients undergoing tumors at San Camillo Forlanini Hospital, Rome, Italy, between June 1, 2018, December...
Yttrium-90 microspheres radioembolization (Y90-RE) has shown to be an effective and safe treatment of primary liver tumors. According the staging system Barcelona Clinic Liver Cancer (BCLC), patients with macrovascular invasion are staged as BCLC-C. This paper comprises a presentation results following application procedure.From January 2002 December 2015, 367 were transplanted at San Camillo Hospital Center. One hundred forty-three for hepatocellular carcinoma (HCC) in 22 cases treated...
Patients with hepatocellular carcinoma (HCC) are selected for liver transplantation (LT) based on pre-LT imaging ± alpha-foetoprotein (AFP) level, but discrepancies between tumour assessment and explant frequent. Our aim was to design an explant-based recurrence risk reassessment score refine prediction of after LT provide a framework guide post-LT management.Adult patients who underwent 2000 2018 HCC in 47 centres were included. A model developed using competing-risk regression analysis...
Despite gaining wide consensus in the management of hepatocellular carcinoma (HCC), minimally invasive liver surgery (MILS) has been poorly investigated for its role setting salvage transplantation (SLT). A multicenter retrospective analysis was carried out 6 Italian centers on 211 patients with HCC who were initially resected open (n = 167) versus MILS 44) and eventually wait-listed SLT. The secondary endpoint identification risk factors posttransplant death tumor recurrence. enrolled...
Good outcomes after liver transplantation (LT) have been reported successfully downstaging to Milan criteria in more advanced hepatocellular carcinoma (HCC). We aimed compare post-LT patients receiving locoregional therapies (LRT) before LT according and University of California San Francisco (UCSF-DS) protocol 'all-comers'.This multicentre cohort study included who received any LRT from Europe Latin America (2000-2018). excluded with alpha-foetoprotein (AFP) above 1,000 ng/ml. Competing...
The use of cadaveric vein allografts was first described by our group as a feasible option for venous reconstruction. aim this study to report long-term results innovative technique.Cold-stored veins harvested from donor cadavers were used homologous grafts reconstruction after vascular resection during pancreaticoduodenectomy. Surgical technique included patch closure or segmental interposition. Graft patency assessed computed tomography postoperatively and follow-up. Postoperative...
Introduction: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has been described to treat hepatocellular carcinoma (HCC) but burdened, in its pioneering phase, by high morbidity mortality. With the advent of minimally invasive (MI) techniques surgery, surgical complications, including posthepatectomy failure (PHLF), have dramatically reduced. The primary endpoint this study was compare short-term outcomes MI- versus open-ALPPS HCC, with specific focus on...